The Hidden Cardiovascular Risk: Spotlight on Elevated Lipoprotein(a)

Elevated lipoprotein(a), or Lp(a), is a significant yet underrecognized genetic risk factor for cardiovascular disease affecting 1 in 5 people globally. Despite its prevalence, awareness remains low, with efforts ongoing to integrate Lp(a) testing into heart health strategies, especially in Asia Pacific and Middle East regions.


Devdiscourse News Desk | India | Updated: 24-09-2025 16:12 IST | Created: 24-09-2025 16:12 IST
The Hidden Cardiovascular Risk: Spotlight on Elevated Lipoprotein(a)
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • United States

Ahead of World Heart Day, experts convened to discuss the overlooked risk factor of elevated lipoprotein(a) in cardiovascular health. Known as the "little a with big consequences," this genetic condition affects 1 in 5 individuals globally but is seldom tested, raising urgent calls for awareness.

Key voices from the healthcare sector, including academia and patient advocacy, emphasized the need to incorporate Lp(a) testing into national heart health guidelines. Despite its significant role in heart disease, the condition remains largely invisible in current health strategies, particularly in Asia Pacific and Middle East regions.

Survey data highlights a critical knowledge gap, with only 22% aware of Lp(a) testing and just 7% having undergone testing. Experts urge immediate action to integrate Lp(a) detection into healthcare systems to save lives by addressing this silent risk factor.

Give Feedback